GE Healthcare Partner With Boston Scientific To Advance Cardiac Care In Southeast Asia
Recently, GE Healthcare has established partnerships with providers such as Amazon Web Services and Optellum, along with Sophia Genetics, the University of Cambridge, and various others, all with the aim of improving clinical care in a number of various ways.
GE Healthcare’s most recent collaboration, which will be its first this year, sees the medtech giant join forces with another very powerful presence in the field, Boston Scientific, with the goal of improving and upgrading cardiac care in the region of Southeast Asia.
The partnership will bring together GE’s imaging software with Boston Scientific’s medical devices which are focused around the heart. Together, these offerings will further improve cardiac care through the use of more advanced diagnostic and interventional tools.
For GE and Boston Scientific, the partnership is their first in Southeast Asia. Together, both companies intend to target cardiovascular disease deaths in the region, the number of which is exacerbated by cultural and socioeconomic diversity, as well as a lack of reliable healthcare services in the area.
Chris Khang, the president and CEO of GE Healthcare’s Southeast Asia business, had the following to say:
“Bridging the industry gap in providing an end-to-end cardiac care center for healthcare providers, this partnership will see the integration of cardiac care solutions, from cath labs to intravascular ultrasound, serving as a comprehensive portfolio for heart surgeons. These solutions will be crucial in unlocking the potential of interventional cardiology and is a step forward in delivering precision health to the region.” Boston Scientific Korea and ASEAN vice-president and managing director Min Hang Heo said: “By integrating access to the latest medical innovations and cutting-edge technology for our joint customers and the patients they care for, we can ensure treatment of patients of all degrees of complexity is readily available.” Southeast Asia has long been a place of operations for GE Healthcare, and the company has formed many partnerships over the years to enhance clinical care. For instance, it teamed up with Singapore’s Agency for Science, Technology and Research, otherwise known as A*STAR, in 2014, marking the beginning of a five-year project to develop new medical technology in response to the rising prevalence of cancer and chronic diseases as life expectancy increases. GE’s healthcare business is partnering with Boston Scientific and flourishing with a number of clinical partnerships as it prepares to become a stand-alone company. GE Healthcare will be an independent company as soon as the spinoff is completed – likely in early 2023.
© GE Healthcare
© Boston Scientific